Regulatory frameworks in developing countries [1] (multiple letters)

Nature Biotechnology

Volumn 23, Issue 4, 2005, Pages 413-414

  Longstaff, Colin ^a   Thelwell, Craig ^a   Whitton, Colin ^a   Thorsteinsdóttir, Halla ^b   Daar, Abdallah S ^b  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE; RECOMBINANT PROTEIN;

BIOTECHNOLOGY; CARDIOVASCULAR DISEASE; COMMERCIAL PHENOMENA; DEVELOPING COUNTRY; DRUG INDUSTRY; DRUG RESEARCH; DRUG SCREENING; ECONOMICS; LETTER; PRIORITY JOURNAL; REGULATORY MECHANISM; DRUG APPROVAL; GENETICS; GOVERNMENT REGULATION; LEGAL ASPECT; LICENSING; MEDICAL LITERATURE; STANDARD;

BIOTECHNOLOGY; DEVELOPING COUNTRIES; DRUG APPROVAL; DRUG INDUSTRY; GOVERNMENT REGULATION; LICENSURE; PHARMACOPOEIAS; RECOMBINANT PROTEINS; STREPTOKINASE;

EID: 23644448925     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0405-413a     Document Type: Letter

References (0)